Novartis | 판매 및 관리 비용



Selling And Administration Expenses 변화 날짜
AbbVie USD 3.29B 562M 2025-03
Alcon AG USD 802M 7M 2024-12
Almirall EUR -50222000 162.22M 2024-06
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Autolus Therapeutics Ltd 33.68M 6.35M 2024-12
Bayer EUR 4.34B 610M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.42B 324.7M 2024-12
Fresenius EUR 769M 68M 2024-12
Fresenius Medical Care EUR 840M 84M 2024-12
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 1.25B 384M 2024-12
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
J&J USD 5.11B 1.34B 2025-03
Merck EUR 1.05B 361M 2024-12
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Orion EUR 84.3M 30.6M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Philips EUR 1.33B 99M 2024-12
Recordati EUR 149.34M 15.49M 2024-09
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03
UCB EUR 533M 434M 2024-06



Novartis 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2025.